Notably, pro-inflammatory mediators can induce maternal hyperglycaemia during GDM by reducing whole-body insulin sensitivity and glucose utilisation [17,18,19], by disrupting insulin signalling pathways in skeletal muscle and white adipose tissue [18,19,20,21,22,23,24]. This evidence concerns the gene INS and gestational diabetes.